FutureGen Industries Provides Shareholder Update on Expanded Investment Strategy in High-Growth Technology Sectors

VANCOUVER, BC / ACCESS Newswire / January 21, 2026 / FutureGen Industries Corp. (formerly Right Season Investments Corp.) (TSXV:LITT,OTC:RMANF) ("FutureGen Industries" or the "Company") is providing an update to its shareholders regarding the Company's expanded investment mandate focused on innovation-driven, high-growth technology sectors. The Company reports that, further to its press release dated June 19, 2025, it intends to advance its strategy by pursuing investment exposure through investments in companies operating within targeted industries, including defense systems, quantum computing, artificial intelligence ("AI"), robotics and biotechnology.

The Company's expanded investment mandate reflects the strategic direction initiated under the leadership of CEO Dr. Kristian Thorlund, as first communicated in the Company's June 19, 2025 announcement regarding its move toward innovation-driven, high-growth potential sectors. Since his appointment, Dr. Thorlund has led the Company in repositioning its portfolio and strategic priorities to aim to capitalize on technological advancement and long-term industry trends. As part of this evolution, the Company is structuring its investment approach to operate in a manner similar to an ETF-style technology strategy, with the goal of enabling exposure to both early-stage innovators and established competitive technology companies across defense systems, AI, biotechnology, robotics, and quantum computing. This model is designed to give investors diversified access to a broad spectrum of emerging and mature technology opportunities through a single investment vehicle.

The market outlook across these sectors continues to strengthen and supports the Company's intended strategic alignment with high growth technology fields. Market data shows that the global artificial intelligence market is expected to grow from 279 billion dollars in 2024 to 1.81 trillion dollars by 2030.[1] The biotechnology industry is projected to expand from 1.55 trillion dollars in 2023 to 3.88 trillion dollars by 2030.[2] The robotics market is also forecast to exceed 200 billion dollars by 2030 with AI driven robotics alone anticipated to reach 124.8 billion dollars.[3] In addition, the global quantum computing market is projected to grow from about 4 billion dollars in 2024 to as much as 72 billion dollars by 2035, with major applications expected across life sciences, chemicals, finance, and mobility.[4] These long term growth projections highlight the scale of the opportunity within these industries and support the Company's strategy of aiming to position itself for value creation across all five sectors.

"Our shift toward targeted investments in these high-growth technology sectors reflects our objective to build a diversified portfolio positioned for long-term growth across structural technology tailwinds. We intend to provide shareholders diversified exposure to innovation-driven and advanced technology markets through a single investment platform," stated Kristian Thorlund, CEO of FutureGen Industries Corp.

About FutureGen Industries Corp.

FutureGen Industries Corp. is a Canadian venture capital, investment and advisory firm that strives to actively drive innovation and accelerate growth for its shareholders. FutureGen invests capital into private and public companies that offer excellent growth opportunities.

Contact:

Kristian Thorlund, CEO
Tel: 1 833 383 9900
Email: investor@futuregenindustries.com

Cautionary and Forward-Looking Statements

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release.

This press release contains forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "potential," and similar expressions, or that events or conditions "will," "would," "may," "could," or "should" occur. Although FutureGen believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in forward-looking statements. Forward-looking statements are based on the beliefs, estimates, and opinions of FutureGen' management on the date the statements are made. FutureGen undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates, or opinions, or other factors, should change, except as required by law.

[1] https://www.grandviewresearch.com/industry-analysis/artificial-intelligence-ai-market

[2] https://www.grandviewresearch.com/horizon/outlook/biotechnology-market-size/global

[3] https://statzon.com/insights/global-robotics-market-growing-rapidly

[4] https://www.mckinsey.com/capabilities/tech-and-ai/our-insights/the-year-of-quantum-from-concept-to-reality-in-2025

SOURCE: FutureGen Industries



View the original press release on ACCESS Newswire

News Provided by ACCESS Newswire via QuoteMedia

LITT:CC
The Conversation (0)
Lobe Sciences Advances Governance and Capital Markets Expertise with Appointment of Mr. Nick Karakochuk to the Board of Directors

Lobe Sciences Advances Governance and Capital Markets Expertise with Appointment of Mr. Nick Karakochuk to the Board of Directors

VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / January 13, 2026 / lobe sciences ltd. ("Lobe Sciences" or the "Company") (CSE:LOBE)(OTCQB:LOBEF)(FWB:LOBE.F), a clinical-stage biopharmaceutical company focused on advancing therapies for diseases with significant unmet medical needs, today... Keep Reading...
Lobe Sciences Reports FY2025 with a Stronger Balance Sheet and Sharpened Strategy

Lobe Sciences Reports FY2025 with a Stronger Balance Sheet and Sharpened Strategy

Balance Sheet and Sharpened Strategy VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / January 8, 2026 / lobe sciences ltd. (CSE:LOBE)(OTCQB:LOBEF)(Frankfurt:LOBE.F) ("Lobe" or the "Company"), a biopharmaceutical company advancing programs in diseases with unmet medical needs, today reported... Keep Reading...
Solvonis Therapeutics

U.S. Patent allowance received for PTSD discovery programme

Solvonis Therapeutics plc (LSE: SVNS), an emerging biopharmaceutical company developing novel medicines for high-burden central nervous system ("CNS") disorders, announces that it has received a Notice of Allowance (the "Allowance") from the United States Patent and Trademark Office ("USPTO")... Keep Reading...
Lobe Sciences Reports Fiscal 2025 Results and Highlights Strategic Transformation Following Leadership Transition

Lobe Sciences Reports Fiscal 2025 Results and Highlights Strategic Transformation Following Leadership Transition

VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / January 6, 2026 / lobe sciences ltd. (CSE:LOBE)(OTCQB:LOBEF)(FWB:LOBE.F) ("Lobe" or the "Company"), a biopharmaceutical company advancing programs in diseases with unmet medical needs, today reported audited financial results for the fiscal year... Keep Reading...
Numinus Wellness Provides Corporate Update

Numinus Wellness Provides Corporate Update

Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, is providing a corporate update.Change of auditorsOn October 10,... Keep Reading...
Numinus Wellness Announces Change of Auditor

Numinus Wellness Announces Change of Auditor

Numinus Wellness Inc. (TSX: NUMI) (OTCQB: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, announces that Davidson & Company LLP ("Davidson") has resigned as... Keep Reading...

Interactive Chart

Latest Press Releases

Related News